Feinberg/Nature Conference Explores Epigenetics
Feinberg partnered with Nature Genetics and Nature Medicine to host the Chicago Science 2019: Epigenetics and Genome Editing conference.
Browsing: "Cancer"
Radiation Plus Chemotherapy Doesn’t Improve Endometrial Cancer Recurrence-Free Survival
In a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in women with stage III/IVA endometrial cancer following surgery.
Uncovering Enzyme’s Dual Role in Cancer Suppression and Growth
A new Northwestern Medicine study has uncovered how a key enzyme in mitochondria can function as both a cancer suppressor and cancer promoter.
Drug Improves Survival in Relapsed Chronic Lymphocytic Leukemia
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.
Drug Shows Benefit in Metastatic Osteosarcoma
A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
Artificial Intelligence System Spots Lung Cancer Before Radiologists
An artificial intelligence system was able to detect malignant lung cancer nodules on CT scans as well as — or better — than expert radiologists, according to a new study.
Mutations Synergize in Pediatric Brain Cancer
A new Northwestern Medicine study has demonstrated that a combination of two mutations makes a form of pediatric brain tumors more deadly.
Vaccine Design May Dramatically Improve Cancer Immunotherapies
The structure of spherical nucleic acids has the potential to improve the effectiveness of vaccines as well as cancer immunotherapies, according to a new study.
Mixed Results for New Lymphoma Therapy
A relatively newer and more complex therapy for diffuse large B-cell lymphoma did not show improvement over the current standard of care, but provides important new context for how the cancer affects treatment options.
New Drug Shows Promise for Relapsed Ovarian Cancers
A drug called niraparib showed clinically relevant activity in women with relapsed ovarian cancer who had exhausted all previous treatment options, according to a recent study.